About Us

PapEasy is a multi-national team of scientists, researchers, physicians, entrepreneurs, professors and allied health professionals who are passionately dedicated to ending cervical cancer for women around the world.

What we’re made of and what we’ve made

Founded in 2020, PapEasy stepped up to eradicate cervical cancer – a cancer that kills half a million women around the world each year, despite it being preventable and treatable. We set our sights high. And we established a team of experts from around the world. 

PapEasy offers a preventative healthcare device that is simple, easy-to-use, and which incorporates artificial intelligence to continually enhance and improve user experience for each woman in real time. By privileging privacy, accessibility, speed, and regional and cultural specificity, PapEasy enables more women to self-screen – or be screened by a healthcare practitioner – more comfortably, quickly and frequently. Our deliverable is the launch of a global movement aimed at eliminating cervical cancer mortality around the world. PapEasy is poised to achieve this through its efficient, effective, and user-friendly end-to-end solution. PapEasy is a multipurpose testing solution which can facilitate two other common tests, STD & HPV in one package.

Why PapEasy

We held a deep conviction that if women everywhere could access the right tool to protect themselves, that we could help women live. This is PapEasy: a belief, a movement, and a slender, flexible wand containing a microscopic, state-of-the-art camera. Our Mission is to develop user friendly self-testing methodologies for the most common gynecological tests and screens, providing critical technological and user experience upgrades, bringing the OB-GYN standard-of-care model into the 21st century.

Fast & Reliable Service

Patient Oriented

Global Accessibility

Educational Programs

Our Team

Founder, C.E.O.

Kamran Ayagh
Chief Scientific Officer

Karen Yeates, M.D
Chief Medical Officer

Dr. Julie Ann Francis
Chief Technology Officer

Dr. Carlos Conde, CTO

Founder, C.E.O.

Kamran Ayagh

Kamran Ayagh is a passionate medical innovator, entrepreneur, and inventor, with more than 30 years of experience in leadership, R & D, marketing, and mechanical engineering. Kamran’s background and travels have given him a very personal motivation to address the global inequalities and struggles that women endure fighting for access to healthcare, government, and basic human rights..

As the founder and CEO of Quest Active Care, a functional medicine facility that focused on health and wellness through scientific testing and preventative medicine, Kamran (and Quest) have achieved sustained market leadership with national and international expansion in progress. Serving a audience of women in a patient-centric practice has given Kamran a unique perspective into not just women’s health, but their attitudes and opinions about preventative health.

After numerous personal losses to cervical cancer, Kamran, designed PapEasy. Armed with the knowledge that cervical cancer is preventable with earlier, easier, and more affordable access to screening, PapEasy is the heart of Kamran’s vision is to conquer the global cervical cancer crisis by eliminating barriers to Pap Smears and putting lifesaving power into the hands of women, one test at a time. With PapEasy Kamran has created a visionary approach that will use technology to stop cervical cancer before it can start.

Chief Scientific Officer

Karen Yeates, M.D

M.D. – Chief Scientific Officer  (Cervical Cancer R&D) and team member, Ms. Ann Taite from Queens University

Chief Medical Officer

Dr. Julie Ann Francis

Dr. Julie Ann Francis is a gynecologic oncologist who completed Obstetrics and Gynecology residency at McMaster University, followed by a clinical fellowship in Gynecologic Oncology at Western University. She spent the first decade of her career at Queen’s University and Kingston Health Sciences Centre, where she served as Division Head. She later joined Lakeridge Health, where she founded the Gynecologic Oncology program and now serves as Division Head and Regional Lead for Colposcopy. She has held an academic appointment as Assistant Professor at Queen’s University since 2008. Her clinical and leadership work focuses on improving prevention, early detection, and treatment of gynecologic cancers, including cervical cancer. She continues to provide care in Kingston and across the Durham region.

Chief Technology Officer

Dr. Carlos Conde, CTO

Dr. Carlos Conde is a Medical Technology Scientist in charge of the PapEasy product and technology line’s development and enhancement as the CTO. He holds a Ph.D. in physical chemistry from the University of Puerto Rico and has extensive expertise in the medical and pharmaceutical industries, including designing, leading, and introducing innovative products and procedures.

Antonio Tito, Ph.D. – Clinical Trials

Amir Banitaba – Operations & Regulatory Affairs

Gary Brennan – Regulatory Affairs

Shahrokh Falati – External Legal Council (IP)

Our Collaborations & Sponsors

PAPEASY

Linkedin Instagram Youtube

Our Practices

Useful Links

Contact

  • Papeasy. All Copyright Reserved